|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1717 PENNSYLVANIA AVENUE, NW |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 24806-12
|
||||||||
|
6. House ID# 336110000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Anders Gilberg |
Date | 7/20/2023 3:17:56 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Regulation in healthcare: submitted written comment to House Small Business Committee on "Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses" hearing
MACRA: supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act; submitted written comment to House Energy & Commerce Committee on MACRA Checkup: Assessing Implementation and Challenges that Remain for Patients and Doctors hearing
Telehealth: submitted written comment to House Energy & Commerce Committee on the SUPPORT Act reauthorization
Prior authorization: submitted written comment to the Senate Committee on Homeland Security and Government Affairs on Examining Health Care Denials and Delays in Medicare Advantage hearing
Patient ID: joined sign-on letter to House and Senate appropriations leaderships to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2024 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique patient health identifier standard
HIPAA: submitted written comment to CMS on HIPAA attachment standards proposed rule
CCM: supported H.R. 2829, Chronic Care Management Act of 2023
Labs: supported S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA)
Healthcare transparency: submitted written comment to House Ways and Means Committees on Health Care Price Transparency: A Patients Right to Know hearing
HTI-1 proposals: submitted written comment to ONC regarding Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing proposed rule
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anders |
Gilberg |
|
|
|
Claire |
Ernst |
|
|
|
James |
Haynes |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Regulation in healthcare: submitted written comment to House Small Business Committee on "Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses" hearing
MACRA: supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act; submitted written comment to House Energy & Commerce Committee on MACRA Checkup: Assessing Implementation and Challenges that Remain for Patients and Doctors hearing
Telehealth: submitted written comment to House Energy & Commerce Committee on the SUPPORT Act reauthorization
Prior authorization: submitted written comment to the Senate Committee on Homeland Security and Government Affairs on Examining Health Care Denials and Delays in Medicare Advantage hearing
Patient ID: joined sign-on letter to House and Senate appropriations leaderships to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2024 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique patient health identifier standard
HIPAA: submitted written comment to CMS on HIPAA attachment standards proposed rule
CCM: supported H.R. 2829, Chronic Care Management Act of 2023
Labs: supported S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA)
Healthcare transparency: submitted written comment to House Ways and Means Committees on Health Care Price Transparency: A Patients Right to Know hearing
HTI-1 proposals: submitted written comment to ONC regarding Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing proposed rule
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Claire |
Ernst |
|
|
|
Anders |
Gilberg |
|
|
|
James |
Haynes |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |